(Auto)Antibodies in Inflammatory Bowel Diseases

Gastroenterology Clinics of North America

Volumn 37, Issue 2, 2008, Pages 429-438

  Vermeire, Severine ^a   Vermeulen, Nathalie ^a   Van Assche, Gert ^a   Bossuyt, Xavier ^a   Rutgeerts, Paul ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CBIR1 ANTIBODY; CHITOBIOSIDE ANTIBODY; COLON EXTRACT ANTIBODY; ERYTHROCYTE ANTIBODY; GLYCAN ANTIBODY; GOBLET CELL ANTIBODY; I2 ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LAMINARIBIOSIDE ANTIBODY; MANNOBIOSIDE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; OMPC ANTIBODY; PANCREATIC ANTIBODY; SACCHAROMYCES CEREVISIAE PROTEIN;

ANTIGEN ANTIBODY REACTION; AUTOIMMUNE HEPATITIS; CANDIDA; COLON BIOPSY; COLONOSCOPY; COMPARATIVE STUDY; CROHN DISEASE; ENTERITIS; ESCHERICHIA COLI; GASTROENTERITIS; HUMAN; MYCOBACTERIUM; PHENOTYPE; REVIEW; SCLEROSING CHOLANGITIS; SENSITIVITY ANALYSIS; ULCERATIVE COLITIS; WESTERN BLOTTING;

AUTOANTIBODIES; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 43549097543     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2008.03.001     Document Type: Review

References (44)

1. Broberger O., and Perlmann P. Autoantibodies in human ulcerative colitis. J Exp Med 110 (1959) 657-674
2. Sendid B., Colombel J.F., Jacquinot P.M., et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 3 (1996) 219-226
3. Rump J.A., Scholmerich J., Gross V., et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology 181 (1990) 406-413
4. Harrison W.J. Autoantibodies against intestinal and gastric mucous cells in ulcerative colitis. Lancet 1 (1965) 1346-1350
5. Vasiliauskas E.A., Plevy S.E., Landers C.J., et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 110 (1996) 1810-1819
6. Satsangi J., Landers C.J., Welsh K.I., et al. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease. Inflamm Bowel Dis 4 (1998) 18-26
7. Seibold F., Slametschka D., Gregor M., et al. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 107 (1994) 532-536
8. Targan S.R., Landers C., Vidrich A., et al. High titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 108 (1995) 1159-1166
9. Seibold F., Weber P., Schöning A., et al. Neutrophil antibodies in chronic liver disease and inflammatory bowel disease: do they react with different antigens?. Eur J Gastroenterol Hepatol 8 (1996) 1095-1100
10. Vermeulen N., Arijs I., Joossens S., et al. Anti-{alpha}-enolase antibodies in patients with inflammatory bowel disease. Clin Chem 54 (2008) 534-541
11. Terjung B., Spengler U., Sauerbruch T., et al. "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 119 (2000) 310-322
12. Sandborn W.J., Loftus E.V., Colombel J.F., et al. Utility of perinuclear anti-neutrophil cytoplasmic antibodies (pANCA) as serologic markers in a population based cohort of patients with Crohn's disease and ulcerative colitis. Gastroenterology 118 (2000) A696
13. Korsmeyer S.J., Williams R.C., Wilson D., et al. Lymphocytotoxic antibody in inflammatory bowel disease. N Engl J Med 22 (1975) 1117-1120
14. Fiocchi C., Roche J.K., and Michener W.M. High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives. Ann Intern Med 110 (1989) 786-794
15. Berberian L.S., Valles-Ayoub Y., Gordon L.K., et al. Expression of a novel autoantibody defined by the Vh3-15 gene in inflammatory bowel disease and Campylobacter jejuni enterocolitis. J Immunol 153 (1994) 3756-3763
16. Seibold F., Weber P., Jenss H., et al. Antibodies to a trypsin-sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease. Gut 32 (1991) 1192-1197
17. Joossens S., Vermeire S., Van Steen K., et al. Pancreatic autoantibodies in inflammatory bowel disease. Inflamm Bowel Dis 10 6 (2004) 771-777
18. Main J., Mc Kenzie H., Yeaman G.R., et al. Antibody to Saccharomyces cerevisiae (baker's yeast) in Crohn's disease. BMJ 297 (1988) 1105-1106
19. Vermeire S., Peeters M., Vlietinck R., et al. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 7 1 (2001) 8-15
20. Quinton J.F., Sendid B., Reumaux D., et al. Anti-Saccharomyces cereviasiae mannan antibodies combined with anti-neutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42 (1998) 788-791
21. Peeters M., Geypens B., Claus D., et al. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 113 (1997) 802-807
22. Ruemmele F.M., Targan S.R., Levy G., et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 115 (1998) 822-829
23. Landers C.J., Cohavy O., Misra R., et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 123 (2002) 689-699
24. Mow W.S., Vasiliauskas E.A., Lin Y.C., et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 126 (2004) 414-424
25. Targan S.R., Landers C.J., Yang H., et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 128 (2005) 2020-2028
26. Dotan I., Fishman S., Dgani Y., et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 131 (2006) 366-378
27. Ferrante M., Henckaerts L., Joossens M., et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 56 (2007) 1394-1403
28. Dubinsky M.C., Ofman J.J., Urman M., et al. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 96 (2001) 758-765
29. Joossens S., Reinisch W., Vermeire S., et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology 122 (2002) 1242-1247
30. Joossens S., Colombel J.F., Landers C., et al. Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis. Gut 55 (2006) 1667-1669
31. Seibold F., Weber P., Klein R., et al. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 33 (1992) 657-662
32. Sendid B., Quinton J.F., Charrier G., et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 93 (1998) 1306-1310
33. Sutton C.L., Yang H., Rotter J.I., et al. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 46 (2000) 58-63
34. Shanahan F., Duerr R., and Rotter J.I. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 103 (1992) 456-461
35. Folwaczny C., Noehl N., Endres S.P., et al. Antinuclear autoantibodies in patients with inflammatory bowel disease-high prevalence in first-degree relatives. Dig Dis Sci 42 (1997) 1593-1596
36. Reumaux D., Colombel J.F., Delecourt L., et al. Antineutrophil cytoplasmic autoantibodies in relatives of patients with ulcerative colitis. [letter]. Gastroenterology 103 (1992) 1706
37. Yang P., Jarnerot G., Danielsson D., et al. pANCA in monozygotic twins with inflammatory bowel disease. Gut 36 (1995) 887-890
38. Lee C.W., Lennard-Jones J.E., and Cambridge G. Antineutrophil antibodies in familial inflammatory bowel disease. Gastroenterology 108 (1995) 428-433
39. Israeli E., Grotto I., Gilburd B., et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 54 (2005) 1232-1236
40. Devlin S.M., Yang H., Ippoliti A., et al. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. Gastroenterology 132 (2007) 576-586
41. Henckaerts L.C., Pierik M., Joossens M., et al. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut 56 (2007) 1536-1542
42. Dubinsky M.C., Lin Y.C., Dutridge D., et al. Western regional pediatric IBD research alliance. Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression. Am J Gastroenterol 101 (2006) 360-367
43. Vecchi M., Bianchi M.B., Calabresi C., et al. Long-term observation of the perinuclear anti-neutrophil cytoplasmic antibody status in ulcerative colitis patients. Scand J Gastroenterol 33 (1998) 170-173
44. Sandborn W.J., Landers C.J., Tremaine W.J., et al. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc 71 (1996) 431-436